Dolby Labs Files 8-K on Officer Changes & Financials
Ticker: DLB · Form: 8-K · Filed: Nov 15, 2024 · CIK: 1308547
| Field | Detail |
|---|---|
| Company | Dolby Laboratories, INC. (DLB) |
| Form Type | 8-K |
| Filed Date | Nov 15, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, financials
Related Tickers: DLB
TL;DR
Dolby Labs 8-K: Officer changes, director elections, and financials filed Nov 15 for Nov 12 events.
AI Summary
Dolby Laboratories, Inc. filed an 8-K on November 15, 2024, reporting events as of November 12, 2024. The filing pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. It also includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates potential shifts in leadership or executive compensation at Dolby Laboratories, which could impact the company's strategic direction and investor confidence.
Risk Assessment
Risk Level: low — This is a routine 8-K filing reporting on corporate governance and financial statements, with no immediate indication of significant negative events.
Key Players & Entities
- Dolby Laboratories, Inc. (company) — Registrant
- November 12, 2024 (date) — Earliest event reported
- November 15, 2024 (date) — Date of report
- 1275 Market Street San Francisco , CA 94103-1410 (address) — Principal executive offices
FAQ
What specific officer departures or appointments are detailed in this 8-K filing?
The filing indicates reporting on the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' but does not provide specific names or details within the provided text.
Are there any new compensatory arrangements for officers mentioned?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item, but the specific details of these arrangements are not included in the provided text.
What is the significance of the 'Financial Statements and Exhibits' being filed?
This indicates that financial information and supporting documents are being provided alongside the corporate event disclosures, as required by SEC regulations.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on November 12, 2024.
What is Dolby Laboratories, Inc.'s principal executive office address?
Dolby Laboratories, Inc.'s principal executive office is located at 1275 Market Street, San Francisco, CA 94103-1410.
Filing Stats: 910 words · 4 min read · ~3 pages · Grade level 14.9 · Accepted 2024-11-15 16:30:55
Key Financial Figures
- $0.001 — which registered Class A common stock, $0.001 par value DLB The New York Stock Ex
Filing Documents
- d882394d8k.htm (8-K) — 28KB
- d882394dex991.htm (EX-99.1) — 8KB
- 0001193125-24-259854.txt ( ) — 156KB
- dlb-20241112.xsd (EX-101.SCH) — 3KB
- dlb-20241112_lab.xml (EX-101.LAB) — 17KB
- dlb-20241112_pre.xml (EX-101.PRE) — 11KB
- d882394d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 2025 Dolby Executive Bonus Plan 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DOLBY LABORATORIES, INC. By: /s/ A NDY S HERMAN Andy Sherman Executive Vice President, General Counsel, and Corporate Secretary Date: November 15, 2024